Abviva, Inc., a development stage biomedical company, focuses on the development and commercialization of breast cancer diagnostic and therapeutic products derived from a human biological secreted protein, Mammastatin. The company, through its subsidiary, develops breast cancer screening products, which include the Mammastatin Serum Assay, a breast cancer diagnostic risk assessment test. It also holds equity interest in Prion Developmental Laboratories, Inc., which develops tests to detect transmissible spongiform encephalopathies, such as mad cow disease in cattle and chronic wasting disease in deer and elk. The company, formerly known as Genesis Bioventures, Inc., was founded in 1994 and is headquartered in Los Angeles, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• No BuyIns.Net Alerts Available for ABVV